| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
NKGN (NKGN) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. NKGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2021 | Garcia Gus | Co-president | Buy | 1,500 | $9.92 | $14,886.00 | +250.0% | |
| May 25, 2021 | Graf James A | Chief Executive Officer | Buy | 1,300 | $9.94 | $12,923.62 | - |